UK markets closed

Burning Rock Biotech Limited (6BU0.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.42000.0000 (0.00%)
As of 03:29PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 61.96M
Enterprise value -9.39M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.37
Price/book (mrq)0.27
Enterprise value/revenue 0.03
Enterprise value/EBITDA -0.16

Trading information

Stock price history

Beta (5Y monthly) 0.18
52-week change 3-87.33%
S&P500 52-week change 323.20%
52-week high 322.2000
52-week low 32.4200
50-day moving average 36.0716
200-day moving average 37.3069

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 510.26M
Implied shares outstanding 6N/A
Float 855.74M
% held by insiders 10.04%
% held by institutions 161.82%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 315 May 2024

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -113.34%
Operating margin (ttm)-100.16%

Management effectiveness

Return on assets (ttm)-31.57%
Return on equity (ttm)-66.95%

Income statement

Revenue (ttm)520.54M
Revenue per share (ttm)50.82
Quarterly revenue growth (yoy)-11.90%
Gross profit (ttm)N/A
EBITDA -472.56M
Net income avi to common (ttm)-589.99M
Diluted EPS (ttm)-7.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)572.62M
Total cash per share (mrq)5.58
Total debt (mrq)19M
Total debt/equity (mrq)2.65%
Current ratio (mrq)3.29
Book value per share (mrq)69.90

Cash flow statement

Operating cash flow (ttm)-182.85M
Levered free cash flow (ttm)-7.68M